Real-world outcomes of women with metastatic breast cancer in visceral crisis treated with chemotherapy: a 15-year cohort from Brazil

Patients with MBC in VC have a poor prognosis even when treated with polychemotherapy. Proper prognostication is crucial for identifying patients who may benefit from active systemic therapy while carefully avoiding potentially futile strategies. Prospective trials including patients with VC criteria are needed to evaluate the efficacy and safety of CT and other emerging therapies in this scenario.